LivaNova
LIVN • NASDAQ
LivaNova is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Vladimir A. Makatsaria, with a market cap of $3.4B.
CEOVladimir A. Makatsaria
Next Earnings
Upcoming earnings announcement for LivaNova
Date
Wednesday, May 6, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.83
Revenue Estimate
$347.5M
Earnings History
Past 12 earnings reports for LivaNova
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Q4 2025 | $0.86Est: $0.76 | +13.2% | $360.9MEst: $353.0M | +2.2% |  10-K |
| Nov 5, 2025 | Q3 2025 | $1.11Est: $0.86 | +29.1% | $357.8MEst: $343.4M | +4.2% | 10-Q |
| Aug 6, 2025 | Q2 2025 | $1.05Est: $0.81 | +29.6% | $352.5MEst: $331.6M | +6.3% | 10-Q |
| May 7, 2025 | Q1 2025 | $0.88Est: $0.76 | +15.8% | $316.9MEst: $302.4M | +4.8% | 10-Q |
| Feb 25, 2025 | Q4 2024 | $0.81Est: $0.80 | +1.3% | $321.8MEst: $324.1M | -0.7% | 10-K |
| Oct 30, 2024 | Q3 2024 | $0.90Est: $0.72 | +25.0% | $318.1MEst: $300.5M | +5.9% | 10-Q |
| Jul 31, 2024 | Q2 2024 | $0.93Est: $0.78 | +19.2% | $318.6MEst: $304.2M | +4.7% | 10-Q |
| May 1, 2024 | Q1 2024 | $0.73Est: $0.49 | +49.0% | $294.9MEst: $278.7M | +5.8% | 10-Q |
| Feb 21, 2024 | Q4 2023 | $0.87Est: $0.77 | +13.0% | $310.1MEst: $287.4M | +7.9% | 10-K |
| Nov 1, 2023 | Q3 2023 | $0.73Est: $0.64 | +14.1% | $286.1MEst: $273.4M | +4.6% | — |
| Jul 26, 2023 | Q2 2023 | $0.78Est: $0.54 | +44.4% | $293.9MEst: $265.5M | +10.7% | 10-Q |
| May 3, 2023 | Q1 2023 | $0.43Est: $0.39 | +10.3% | $263.4MEst: $243.4M | +8.2% | — |